Scott Moore explores China’s trajectory in the worldwide biotechnology sector. Though the United States has become the dominant international player in producing and commercializing biotechnology for decades, China is determined to be a number one player in biotechnology and is also investing heavily while in the sector. Moore argues that, whilst